POINT BIOPHARMA GLOBAL INC. Operating Lease Cost
POINT BIOPHARMA GLOBAL INC. reported Operating Lease Cost of $303.21 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2023-11-13
- POINT BIOPHARMA GLOBAL INC. operating lease, cost for the quarter ending 2023-09-30 was $252.72K.
- POINT BIOPHARMA GLOBAL INC. operating lease, cost for the quarter ending 2022-09-30 was $0.00.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month |
|---|---|---|---|
| 2023-09-30 | $252.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $303.21K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $50.50K 10-Q · filed 2023-08-14 | ||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $0.00 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-14 |